Literature DB >> 8985299

Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis?

A Armonis1, D Patch, A Burroughs.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 8985299     DOI： 10.1053/jhep.1997.v25.ajhep0250245

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  25 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors:  J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

2.  Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

Authors:  Ai Nakagawa; Masanori Atsukawa; Akihito Tsubota; Chisa Kondo; Tomomi Okubo; Taeang Arai; Norio Itokawa; Yoshiyuki Narahara; Katsuhiko Iwakiri
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

Review 3.  Staging of liver fibrosis or cirrhosis: The role of hepatic venous pressure gradient measurement.

Authors:  Ki Tae Suk; Dong Joon Kim
Journal:  World J Hepatol       Date:  2015-03-27

4.  Variceal pressure is a strong predictor of variceal haemorrhage in patients with cirrhosis as well as in patients with non-cirrhotic portal hypertension.

Authors:  E A El Atti; F Nevens; K Bogaerts; G Verbeke; J Fevery
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

Review 5.  Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence.

Authors:  U Thalheimer; M Mela; D Patch; A K Burroughs
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study.

Authors:  Jason Y Huang; Jason B Samarasena; Takeshi Tsujino; John Lee; Ke-Qin Hu; Christine E McLaren; Wen-Pin Chen; Kenneth J Chang
Journal:  Gastrointest Endosc       Date:  2016-09-29       Impact factor: 9.427

7.  Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.

Authors:  Amir A Qamar; Norman D Grace; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Andrew K Burroughs; Cristina Ripoll; Rie Maurer; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Robert Makuch; Gabriel Rendon
Journal:  Clin Gastroenterol Hepatol       Date:  2009-03-10       Impact factor: 11.382

8.  Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.

Authors:  Tze Tong Tey; Apoorva Gogna; Farah Gillan Irani; Chow Wei Too; Hoau Gong Richard Lo; Bien Soo Tan; Kiang Hiong Tay; Hock Foong Lui; Pik Eu Jason Chang
Journal:  Singapore Med J       Date:  2016-03       Impact factor: 1.858

9.  Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis.

Authors:  S Sugano; M Nishio; H Makino; T Suzuki
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

10.  Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection.

Authors:  A Deplano; V Migaleddu; A Pischedda; G Garrucciu; G Gregu; C Multinu; M Piredda; A Tocco; F Urigo; P A Cossu; A Solinas
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.